Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL9187201 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Cyclohexane SCHEMBL473283 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Cyclopentane SCHEMBL9803711 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL21445 | 0.95 | TSHR (0.56) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL5448533 | 0.95 | TSHR (0.56) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL10531929 | 0.92 | TSHR (0.54) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL5922689 | 0.92 | TSHR (0.54) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL13583287 | 0.90 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL21932617 | 0.90 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL262676 | 0.90 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041953-A | Preparation process of menthol modified casein viscose fiber | 松山棉店(北京)科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2023195790-A1 | METHOD FOR MANUFACTURING BIOMATERIAL FOR TISSUE REPAIR WITH EXCELLENT SAFETY | ㈜아크로스 | 2023-10-12 | — | — | WO | claimed |
| WO-2023085832-A1 | METHOD FOR PREPARING COMPOSITION CONTAINING HYALURONIC ACID CROSSLINKED PRODUCT | 주식회사 유영제약 | 2023-05-19 | — | — | WO | claimed |
| CN-113563835-A | Impervious waterproof adhesive for leakage stoppage on back water surface and preparation method thereof | 宋华杰 | 2021-10-29 | — | — | CN | claimed |
| CN-109476830-B | Hardener composition and associated forming process, uncured and cured epoxy resin composition, and article | 沙特基础工业全球技术有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-108290386-B | Method of forming a cured epoxy material, cured epoxy material formed thereby, and composite core incorporating the cured epoxy material | 沙特基础工业全球技术有限公司 | 2021-05-14 | — | — | CN | claimed |
| WO-2020184744-A1 | METHOD FOR PRODUCING COMPLEX | 주식회사 지씨에스 | 2020-09-17 | — | — | WO | claimed |
| EP-1963448-B1 | COATINGS FOR OPTICAL ELEMENTS | CARL ZEISS VISION AUSTRALIA HOLDINGS LTD (AU) | 2018-10-10 | — | — | EP | claimed |
| CN-108290386-A | It forms the method for cured epoxy material, the cured epoxy material formed by it, useful phenylene ether oligomer-anhydride reaction product and combine the composite material core of cured epoxy material in the method | 沙特基础工业全球技术有限公司 | 2018-07-17 | — | — | CN | claimed |
| EP-2566908-A2 | POTTING FOR ELECTRONIC COMPONENTS | Tyco Electronics Services GmbH (CH) | 2013-03-13 | — | — | EP | claimed |
| WO-2011140402-A2 | POTTING FOR ELECTRONIC COMPONENTS | TYCO ELECTRONICS SERVICES GMBH (CH) | 2011-11-10 | — | — | WO | claimed |
| WO-2001008718-A1 | UNIVERSAL BIOCOMPATIBLE COATING PLATFORM FOR MEDICAL DEVICES | EDWARDS LIFESCIENCES CORPORATION (US) | 2001-02-08 | — | — | WO | claimed |
| US-5290685-A | Method for separation and concentration of phosphopeptides | MEIJI MILK PRODUCTS COMPANY LIMITED (JP) | 1994-03-01 | — | — | US | claimed |
| EP-0428882-A2 | Polyepoxide potting resin compositions and electrically conductive coils impregnated therewith | GENERAL ELECTRIC COMPANY (US) | 1991-05-29 | — | — | EP | claimed |
| US-12630668-B2 | Liquid compression molding material | NAMICS CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12454612-B2 | Liquid resin composition for compression molding and electronic component apparatus | RESONAC CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| US-20250277073-A1 | CURABLE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE | FUJIFILM CORPORATION (JP) | 2025-09-04 | — | — | US | disclosed |
| EP-0028937-B1 | ALBUMIN-FIXED RESIN, PROCESS FOR ITS PRODUCTION, METHOD OF USING IT TO REMOVE NOXIOUS SUBSTANCES FROM SOLUTIONS CONTAINING THEM, AND ITS USE IN REMOVING NOXIOUS SUBSTANCES FROM BLOOD | TEIJIN LIMITED (JP) | 1985-05-29 | — | — | EP | disclosed |
| US-4323486-A | Albumin-fixed resin, production thereof, and therapeutical use thereof | TEIJIN LIMITED (JP) | 1982-04-06 | — | — | US | disclosed |
| EP-0028937-A2 | Albumin-fixed resin, process for its production, method of using it to remove noxious substances from solutions containing them, and its use in removing noxious substances from blood | TEIJIN LIMITED (JP) | 1981-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630668-B2 | Liquid compression molding material | PIEZO1, TSNAX, TMCO1 | TSHR 1046/4885ALDH1A1 3204/4885MAPK1 3139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.